BioMarin Expands Rare Disease Portfolio with $270M Inozyme Acquisition
On May 16, BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) announced a $270 million acquisition of Inozyme Pharma, aiming to expand its rare disease research.
Posts Tagged ‘NASDAQ:BMRN’
15 Small-Cap Healthcare Stocks Hedge Funds Are Buying
The U.S. healthcare sector has performed better in 2025 compared to the broader market.
Billionaire Paul Singer’s 10 Stock Picks with Huge Upside Potential
Paul Singer founded Elliott Investment Management in 1977 in New York.
10 Stocks That Will Make You Rich In 3 Years
The stock market has been facing volatility since the tariffs were announced.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2025 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2025 Earnings Call Transcript May 1, 2025BioMarin Pharmaceutical Inc. beats earnings expectations.
Billionaire Andreas Halvorsen’s 10 Stock Picks With Huge Upside Potential
Ole Andreas Halvorsen is one of the prominent names among former employees of Julian Robertson's Tiger Management.
20 Takeover Rumors Hedge Funds Are Buying
Hedge funds tend to pile up on a stock that gains or is expected to gain positive attention in a market.
7 Most Profitable Biotech Stocks To Buy Right Now
With improved market conditions, innovative breakthroughs, and more investor interest, the biotechnology industry is gaining new traction.
11 Best Gene Therapy Stocks to Buy According to Analysts
Gene therapy is a medical approach that entails changing or modifying genes to treat or prevent disease.
12 Most Promising Biotech Stocks According to Wall Street Analysts
The biotechnology sector is gaining new momentum with better market conditions, cutting-edge innovations, and growing investor attention.
Paul Singer’s Latest Portfolio: Top 10 Stock Picks
Stock markets are as risky as they have ever been. That’s the sentiment echoed by billionaire investor Paul Singer.
15 Best Biotech Stocks to Buy According to Billionaires
Although biotech stocks had a "challenging" year in 2024, JPMorgan believes that some of the industry's companies could see significant growth in the months to come.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2024 Earnings Call Transcript February 19, 2025BioMarin Pharmaceutical Inc. beats earnings expectations.
12 Best Healthcare Stocks to Buy According to Analysts
McKinsey reported that, since 2019, the US healthcare industry witnessed significant financial pressure.
12 Best Depressed Stocks to Invest in Now
The US stocks ended 2024 with a healthy Q4, as the equity markets were primarily aided by solid economic growth, healthy earnings momentum, and the expectations of the rate cuts...
10 Under-the-Radar Stocks with Massive Upside for 2025
Investing in under-the-radar stocks can be a savvy move for those looking to diversify their portfolios and potentially reap significant rewards.
10 Worst Performing Healthcare Stocks in 2024
The healthcare industry remains a vital and resilient sector which is driven by advancements in technology, increasing global demand, and an aging population.
10 Worst Performing Biotech Stocks in 2024
Biotechnology stocks are among the most volatile in the market due to their high risk.
10 Best Genomics Stocks To Buy Right Now
Genomics is the study of genes and how they function.
Here’s Why BioMarin Aristotle Large Cap Growth Strategy Divested From Pharmaceutical (BMRN)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” third quarter 2024 investor letter.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q3 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q3 2024 Earnings Call Transcript October 29, 2024BioMarin Pharmaceutical Inc. beats earnings expectations.
10 Best Falling Stocks To Buy According to Hedge Funds
Analysts at Goldman Sachs on October 21st released a note forecasting that the S&P 500 average annual return of 13% for the past 10 years might come down to just 3% for the next...
16 Best Mid Cap Growth Stocks To Buy Now
Recent discussions among financial strategists emphasize the current stock market dynamics, particularly regarding the upcoming US elections.
Top 10 Stock Picks of Elliott Management
It was arguably one of the best years for hedge funds, going by the $67 billion returned to shareholders in 2023 as the overall equity markets shrugged off high interest rates...
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2024 Earnings Call Transcript August 5, 2024BioMarin Pharmaceutical Inc. misses on earnings expectations.
Here’s Why Parnassus Value Equity Fund Sold BioMarin Pharmaceutical (BMRN)
Parnassus Investments, an investment management company, released the “Parnassus Value Equity Fund” first quarter 2024 investor letter.
Should You Hold BioMarin Pharmaceutical (BMRN) Despite Setback?
Scout Investments, Inc, an affiliate of Carillon Tower Advisers, released the “Carillon Scout Mid Cap Fund” first quarter 2024 investor letter.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2024 Earnings Call Transcript
BioMarin Pharmaceutical Inc. beats earnings expectations. Reported EPS is $0.71, expectations were $0.6. BioMarin Pharmaceutical Inc.
30 Biggest Biotechnology Companies in the World
In this article, we will be taking a look at the 30 biggest biotechnology companies in the world.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2023 Earnings Call Transcript
BioMarin Pharmaceutical Inc. misses on earnings expectations. Reported EPS is $0.18 EPS, expectations were $0.44.
20 Fastest Growing Biotech Companies in the US
In this article, we will be taking a look at the 20 fastest growing biotech companies in the US.
Wall Street Analysts Just Trimmed Price Targets for These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
Billionaire Louis Bacon’s 10 Stock Picks with Huge Upside Potential
In this article, we discuss billionaire Louis Bacon's 10 stock picks with huge upside potential. To skip the details about Mr.
Top 20 Drug Companies in the US by Revenue
In this article, we will be taking a look at the top 20 drug companies in the US by revenue.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q3 2023 Earnings Call Transcript
Operator: Hello and welcome to the BioMarin Pharmaceutical Third Quarter 2023 Conference Call. All lines have been placed on meet to prevent any background noise.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q2 2023 Earnings Call Transcript
Operator: Thank you for joining BioMarin Second Quarterly Results Conference Call. Hosting today's call from BioMarin is Traci McCarty, Head of Investor Relations at BioMarin.
Analysts Are Cutting Price Targets of These 5 Stocks
In this article, we discuss the 5 stocks receiving price-target cut from analysts.
10 Martin Shkreli Stock Picks and Their Performance
In this article, we will take a look at the 10 Martin Shkreli stock picks and their performance.
14 Best Biotech Stocks To Buy According To Hedge Funds
In this piece, we will take a look at 14 best biotechnology stocks to buy according to hedge funds.
Here’s Why You Should Invest in BioMarin Pharmaceutical (BMRN)
Aristotle Atlantic Partners, LLC, an investment advisor, released its “Large Cap Growth Strategy” first quarter 2023 investor letter.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q1 2023 Earnings Call Transcript
Operator: Welcome to the BioMarin Pharmaceuticals First Quarter Investor Update Call.
Is BioMarin Pharmaceutical (BMRN) an Attractive Investment?
ClearBridge Investments, an investment management company, released its “ClearBridge Sustainability Leaders Strategy” fourth 2022 investor letter.
BioMarin Pharmaceutical Inc. (NASDAQ:BMRN) Q4 2022 Earnings Call Transcript
Operator: Welcome to the BioMarin Fourth Quarter Investor Update Call.
Top Investors’ Stock Portfolio: 5 Mid-Cap Stocks To Buy
In this article, we discuss 5 best mid-cap stocks to buy according to top investors.
5 Best Genomics Stocks To Buy Now
Agilent Technologies, Inc. (NYSE:A) provides application-focused solutions to the life sciences, diagnostics, and applied chemical markets worldwide.
5 Best Biotech Stocks To Buy According To Hedge Funds
In this article, we discuss 5 best biotech stocks to buy according to hedge funds.
Should You Invest in BioMarin Pharmaceutical (BMRN)?
Carillon Tower Advisers, an investment management company, released its “Carillon Scout Mid Cap Fund” second quarter 2022 investor letter.
Top 10 Stock Picks of Roberto Mignone’s Bridger Management
In this article, we discuss the top 10 stock picks of Roberto Mignone's Bridger Management.
5 Best Biotech Stocks To Buy Now
In this article, we discuss 5 Best Biotech Stocks To Buy Now.
5 Best Healthcare Stocks To Buy Now According To Motley Fool’s 1623 Capital
In this article, we talk about the 5 best healthcare stocks to buy now according to Motley Fool's 1623 Capital.
